{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:31:32Z","timestamp":1765528292067,"version":"3.48.0"},"reference-count":76,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths worldwide. The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. It has high infectivity. The manifestations of the disease range from asymptomatic or mild symptoms to severe pneumonia and ARDS. The CT scan of lung shows consolidation and \u201cGround Glass Opacities\u201d. The persons with other comorbidities are considered to be at a higher rate of acquiring the infection. Asthma and other allergies have not been identified as major risk factors for COVID-19 as the number of asthmatic patients having COVID-19 is not high enough for it to be considered so. The occurrence of COVID-19 in COPD patients can be related with smoking. The ACE-2 expression in such patients was considerably high. The relation between COVID-19 and Tuberculosis can also be reflected in terms of the stigma associated with diagnosis and treatment of such diseases in some communities, eventually increasing the chances of people's reluctance to seek medical help. Cancer patients are usually more susceptible to infections. Lung cancer is no different. Additionally, lung cancer also has strong association with smoking further increasing the risk. The risk of getting infection and its severity is high for autoimmune disorders as well as fungal infections. Currently there is no definite treatment of COVID-19. However, some of the currently used modalities are hydroxychloroquine and antiviral drugs.<\/jats:p>","DOI":"10.1515\/hmbci-2020-0096","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T23:41:20Z","timestamp":1627774880000},"page":"435-443","source":"Crossref","is-referenced-by-count":16,"title":["COVID-19 and lung pathologies"],"prefix":"10.1515","volume":"42","author":[{"given":"Darshana","family":"Purohit","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences , Nagpur , Maharashtra , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-378X","authenticated-orcid":false,"given":"Ashok Kumar","family":"Ahirwar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Nagpur , Maharashtra , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-1227","authenticated-orcid":false,"given":"Apurva","family":"Sakarde","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Nagpur , Maharashtra , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Asia","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Nagpur , Maharashtra , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Gopal","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , All India Institute of Medical Sciences , Nagpur , Maharashtra , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"2025121207243553220_j_hmbci-2020-0096_ref_001","doi-asserted-by":"crossref","unstructured":"Ge, H, Wang, X, Yuan, X, Xiao, G, Wang, C, Deng, T, et al.. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020;39:1011\u201319. https:\/\/doi.org\/10.1007\/s10096-020-03874-z.","DOI":"10.1007\/s10096-020-03874-z"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_002","doi-asserted-by":"crossref","unstructured":"Huang, C, Wang, Y, Li, X, Ren, L, Zhao, J, Hu, Y, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_003","doi-asserted-by":"crossref","unstructured":"Jiang, S, Xia, S, Ying, T, Lu, L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol 2020;17:554. https:\/\/doi.org\/10.1038\/s41423-020-0372-4.","DOI":"10.1038\/s41423-020-0372-4"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_004","doi-asserted-by":"crossref","unstructured":"Bai, Y, Yao, L, Wei, T, Tian, F, Jin, DY, Chen, L, et al.. Presumed asymptomatic carrier transmission of COVID-19. J Am Med Assoc 2020;323:1406\u20137. https:\/\/doi.org\/10.1001\/jama.2020.2565.","DOI":"10.1001\/jama.2020.2565"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_005","doi-asserted-by":"crossref","unstructured":"of the International CS. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5(4):536. https:\/\/doi.org\/10.1038\/s41564-020-0695-z.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_006","unstructured":"World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva (Switzerland): World Health Organization; 2020. Available from: https:\/\/www.who.int\/dg\/speeches\/detail\/whodirector-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 [Accessed 12 Mar 2020]."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_007","unstructured":"Ghinai, I, McPherson, TD, Hunter, JC, Kirking, HL, Christiansen, D, Joshi, K, et al.. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet 2020."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_008","doi-asserted-by":"crossref","unstructured":"Fiorillo, L, Cervino, G, Matarese, M, D'Amico, C, Surace, G, Paduano, V, et al.. COVID-19 surface persistence: a recent data summary and its importance for medical and dental settings. Int J Environ Res Publ Health 2020;17:3132.","DOI":"10.3390\/ijerph17093132"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_009","doi-asserted-by":"crossref","unstructured":"Ong, SW, Tan, YK, Chia, PY, Lee, TH, Ng, OT, Wong, MS, et al.. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. J Am Med Assoc 2020;323:1610\u20132.","DOI":"10.1001\/jama.2020.3227"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_010","doi-asserted-by":"crossref","unstructured":"Van Doremalen, N, Bushmaker, T, Morris, DH, Holbrook, MG, Gamble, A, Williamson, BN, et al.. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020.","DOI":"10.1101\/2020.03.09.20033217"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_011","doi-asserted-by":"crossref","unstructured":"Wu, C, Liu, Y, Yang, Y, Zhang, P, Zhong, W, Wang, Y, et al.. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 2020;10:766\u201388.","DOI":"10.1016\/j.apsb.2020.02.008"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_012","doi-asserted-by":"crossref","unstructured":"Park, SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 2020;63:119.","DOI":"10.3345\/cep.2020.00493"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_013","unstructured":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003; 2003. Available from: http:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/index.html."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_014","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. [Online]. Available from https:\/\/covid19.who.int [Accessed 8 December 2020]."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_015","unstructured":"https:\/\/www.mohfw.gov.in [Accessed on 8 December 2020]."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_016","doi-asserted-by":"crossref","unstructured":"Wang, Y, Wang, Y, Chen, Y, Qin, Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID\u201019) implicate special control measures. J Med Virol 2020;92:568\u201376.","DOI":"10.1002\/jmv.25748"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_017","doi-asserted-by":"crossref","unstructured":"Dong, X, Cao, YY, Lu, XX, Zhang, JJ, Du, H, Yan, YQ, et al.. Eleven faces of coronavirus disease 2019. Allergy 2020;75:1699\u2013709.","DOI":"10.1111\/all.14289"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_018","doi-asserted-by":"crossref","unstructured":"Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708\u201320.","DOI":"10.1056\/NEJMoa2002032"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_019","doi-asserted-by":"crossref","unstructured":"Li, X, Xu, S, Yu, M, Wang, K, Tao, Y, Zhou, Y, et al.. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020.","DOI":"10.1016\/j.jaci.2020.04.006"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_020","doi-asserted-by":"crossref","unstructured":"Singhal, T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020:1\u20136.","DOI":"10.1007\/s12098-020-03263-6"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_021","doi-asserted-by":"crossref","unstructured":"Shi, H, Han, X, Jiang, N, Cao, Y, Alwalid, O, Gu, J, et al.. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20:425\u201334.","DOI":"10.1016\/S1473-3099(20)30086-4"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_022","doi-asserted-by":"crossref","unstructured":"Wichmann, D, Sperhake, JP, L\u00fctgehetmann, M, Steurer, S, Edler, C, Heinemann, A, et al.. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 2020;173:268\u201377.","DOI":"10.7326\/L20-1206"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_023","doi-asserted-by":"crossref","unstructured":"Wang, Y, Lu, X, Li, Y, Chen, H, Chen, T, Su, N, et al.. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med 2020;201:1430\u20134.","DOI":"10.1164\/rccm.202003-0736LE"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_024","doi-asserted-by":"crossref","unstructured":"Tian, S, Hu, W, Niu, L, Liu, H, Xu, H, Xiao, SY. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15:700\u20134.","DOI":"10.1016\/j.jtho.2020.02.010"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_025","doi-asserted-by":"crossref","unstructured":"Xu, Z, Shi, L, Wang, Y, Zhang, J, Huang, L, Zhang, C, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420\u20132.","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_026","doi-asserted-by":"crossref","unstructured":"Lai, CC, Shih, TP, Ko, WC, Tang, HJ, Hsueh, PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924.","DOI":"10.1016\/j.ijantimicag.2020.105924"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_027","doi-asserted-by":"crossref","unstructured":"Tay, MZ, Poh, CM, R\u00e9nia, L, MacAry, PA, Ng, LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363\u201374.","DOI":"10.1038\/s41577-020-0311-8"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_028","doi-asserted-by":"crossref","unstructured":"Lu, R, Zhao, X, Li, J, Niu, P, Yang, B, Wu, H, et al.. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565\u201374.","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_029","doi-asserted-by":"crossref","unstructured":"Wu, A, Peng, Y, Huang, B, Ding, X, Wang, X, Niu, P, et al.. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020;27:325\u20138.","DOI":"10.1016\/j.chom.2020.02.001"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_030","doi-asserted-by":"crossref","unstructured":"Walls, AC, Park, YJ, Tortorici, MA, Wall, A, McGuire, AT, Veesler, D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020;181:281\u201392.","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_031","doi-asserted-by":"crossref","unstructured":"Jia, HP, Look, DC, Shi, L, Hickey, M, Pewe, L, Netland, J, et al.. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 2005;79:14614\u201321.","DOI":"10.1128\/JVI.79.23.14614-14621.2005"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_032","doi-asserted-by":"crossref","unstructured":"Hamming, I, Timens, W, Bulthuis, ML, Lely, AT, Navis, GV, van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol: J Pathol Soc G B Irel 2004;203:631\u20137.","DOI":"10.1002\/path.1570"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_033","doi-asserted-by":"crossref","unstructured":"Xu, H, Zhong, L, Deng, J, Peng, J, Dan, H, Zeng, X, et al.. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12:1\u20135.","DOI":"10.1038\/s41368-020-0074-x"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_034","doi-asserted-by":"crossref","unstructured":"Zhou, P, Yang, XL, Wang, XG, Hu, B, Zhang, L, Zhang, W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270\u20133.","DOI":"10.1038\/s41586-020-2012-7"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_035","doi-asserted-by":"crossref","unstructured":"Simmons, G, Gosalia, DN, Rennekamp, AJ, Reeves, JD, Diamond, SL, Bates, P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci Unit States Am 2005;102:11876\u201381.","DOI":"10.1073\/pnas.0505577102"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_036","doi-asserted-by":"crossref","unstructured":"Hoffmann, M, Kleine-Weber, H, Schroeder, S, Kr\u00fcger, N, Herrler, T, Erichsen, S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271\u201380.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_037","doi-asserted-by":"crossref","unstructured":"Yang, M. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection; 2020. Available at SSRN 3527420.","DOI":"10.2139\/ssrn.3527420"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_038","doi-asserted-by":"crossref","unstructured":"Zhang, B, Zhou, X, Qiu, Y, Feng, F, Feng, J, Jia, Y, et al.. Clinical characteristics of 82 death cases with COVID-19. MedRxiv 2020.","DOI":"10.1101\/2020.02.26.20028191"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_039","doi-asserted-by":"crossref","unstructured":"Zhang, JJ, Dong, X, Cao, YY, Yuan, YD, Yang, YB, Yan, YQ, et al.. Clinical characteristics of 140 patients infected with SARS\u2010CoV\u20102 in Wuhan, China. Allergy 2020;75:1730\u201341.","DOI":"10.1111\/all.14238"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_040","doi-asserted-by":"crossref","unstructured":"Agache, I, Akdis, CA. Endotypes of allergic diseases and asthma: an important step in building blocks for the future of precision medicine. Allergol Int 2016;65:243\u201352.","DOI":"10.1016\/j.alit.2016.04.011"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_041","doi-asserted-by":"crossref","unstructured":"Gonzales\u2010van Horn, SR, Farrar, JD. Interferon at the crossroads of allergy and viral infections. J Leukoc Biol 2015;98:185\u201394.","DOI":"10.1189\/jlb.3RU0315-099R"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_042","doi-asserted-by":"crossref","unstructured":"Corne, JM, Marshall, C, Smith, S, Schreiber, J, Sanderson, G, Holgate, ST, et al.. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831\u20134.","DOI":"10.1016\/S0140-6736(02)07953-9"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_043","doi-asserted-by":"crossref","unstructured":"Liu, S, Zhi, Y, Ying, S. COVID-19 and asthma: reflection during the pandemic. Clin Rev Allergy Immunol 2020;59:78\u201388.","DOI":"10.1007\/s12016-020-08797-3"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_044","doi-asserted-by":"crossref","unstructured":"Qin, C, Zhou, L, Hu, Z, Zhang, S, Yang, S, Tao, Y, et al.. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020;71:762\u20138.","DOI":"10.1093\/cid\/ciaa248"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_045","doi-asserted-by":"crossref","unstructured":"Russell, CD, Millar, JE, Baillie, JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473\u20135.","DOI":"10.1016\/S0140-6736(20)30317-2"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_046","doi-asserted-by":"crossref","unstructured":"Peters, MC, Sajuthi, S, Deford, P, Christenson, S, Rios, CL, Montgomery, MT, et al.. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 2020;202:83\u201390.","DOI":"10.1164\/rccm.202003-0821OC"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_047","doi-asserted-by":"crossref","unstructured":"Johnston, SL. Asthma and COVID\u201019: is asthma a risk factor for severe outcomes? Allergy 2020;75:1543\u20135.","DOI":"10.1111\/all.14348"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_048","unstructured":"GOLD. Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/11\/GOLD-2020-REPORT-ver1.0wms.pdf."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_049","doi-asserted-by":"crossref","unstructured":"Alqahtani, JS, Oyelade, T, Aldhahir, AM, Alghamdi, SM, Almehmadi, M, Alqahtani, AS, et al.. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PloS One 2020;15: e0233147.","DOI":"10.1371\/journal.pone.0233147"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_050","doi-asserted-by":"crossref","unstructured":"Leung, JM, Yang, CX, Tam, A, Shaipanich, T, Hackett, TL, Singhera, GK, et al.. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 2020;55.","DOI":"10.1101\/2020.03.18.20038455"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_051","doi-asserted-by":"crossref","unstructured":"Sharif-Askari, NS, Sharif-Askari, FS, Alabed, M, Temsah, MH, Alheialy, S, Hamid, Q, et al.. Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD. Mol Ther-Methods Clin Dev 2020;18:1\u20136.","DOI":"10.1016\/j.omtm.2020.05.013"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_052","unstructured":"Saunders, MJ, Evans, CA. COVID-19, tuberculosis, and poverty: preventing a perfect storm."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_053","unstructured":"4 World Health Organization. Global tuberculosis report 2019; 2019. Geneva."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_054","unstructured":"Liu, Y, Bi, L, Chen, Y, Wang, Y, Fleming, J, Yu, Y, et al.. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. Medrxiv 2020."},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_055","doi-asserted-by":"crossref","unstructured":"Motta, I, Centis, R, D\u2019Ambrosio, L, Garc\u00eda-Garc\u00eda, JM, Goletti, D, Gualano, G, et al.. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020;26:233\u201340.","DOI":"10.1016\/j.pulmoe.2020.05.002"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_056","doi-asserted-by":"crossref","unstructured":"Amimo, F, Lambert, B, Magit, A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Trop Med Health 2020;48:1\u20134.","DOI":"10.1186\/s41182-020-00219-6"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_057","doi-asserted-by":"crossref","unstructured":"Chen, W, Zheng, R, Baade, PD, Zhang, S, Zeng, H, Bray, F, et al.. Cancer statistics in China, 2015. CA A Cancer J Clin 2016;66:115\u201332.","DOI":"10.3322\/caac.21338"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_058","doi-asserted-by":"crossref","unstructured":"Liang, W, Guan, W, Chen, R, Wang, W, Li, J, Xu, K, et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335\u20137.","DOI":"10.1016\/S1470-2045(20)30096-6"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_059","doi-asserted-by":"crossref","unstructured":"Dai, M, Liu, D, Liu, M, Zhou, F, Li, G, Chen, Z, et al.. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Canc Discov 2020;10:783\u201391.","DOI":"10.1158\/2159-8290.CD-20-0422"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_060","doi-asserted-by":"crossref","unstructured":"Dingemans, AM, Soo, RA, Jazieh, AR, Rice, SJ, Kim, YT, Teo, LL, et al.. Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic. J Thorac Oncol 2020;15:1119\u201336.","DOI":"10.1016\/j.jtho.2020.05.001"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_061","doi-asserted-by":"crossref","unstructured":"Kong, Q, Xiang, Z, Wu, Y, Gu, Y, Guo, J, Geng, F. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection. Mol Canc 2020;19:1\u20135.","DOI":"10.1186\/s12943-020-01209-2"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_062","doi-asserted-by":"crossref","unstructured":"Calandri, M, Solitro, F, Angelino, V, Moretti, F, Veltri, A. The role of radiology in the evaluation of the immunotherapy efficacy. J Thorac Dis 2018;10(Suppl 13):S1438.","DOI":"10.21037\/jtd.2018.05.130"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_063","doi-asserted-by":"crossref","unstructured":"Doran, MF, Crowson, CS, Pond, GR, O'Fallon, WM, Gabriel, SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population\u2010based study. Arthritis Rheum 2002;46:2287\u201393.","DOI":"10.1002\/art.10524"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_064","doi-asserted-by":"crossref","unstructured":"Favalli, EG, Ingegnoli, F, De Lucia, O, Cincinelli, G, Cimaz, R, Caporali, R. COVID-19 infection and rheumatoid arthritis: Faraway, so close!. Autoimmun Rev 2020;19:102523.","DOI":"10.1016\/j.autrev.2020.102523"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_065","doi-asserted-by":"crossref","unstructured":"Sweiss, NJ, Korsten, P, Syed, H, Syed, A, Baughman, RP, Yee, AM, et al.. When the game changes: guidance to adjust sarcoidosis management during the COVID-19 pandemic. Chest 2020;158:892\u20135.","DOI":"10.1016\/j.chest.2020.04.033"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_066","doi-asserted-by":"crossref","unstructured":"Koehler, P, Cornely, OA, B\u00f6ttiger, BW, Dusse, F, Eichenauer, DA, Fuchs, F, et al.. COVID\u201019 associated pulmonary aspergillosis. Mycoses 2020;63:528\u201334.","DOI":"10.1111\/myc.13096"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_067","doi-asserted-by":"crossref","unstructured":"Koehler, P, Bassetti, M, Kochanek, M, Shimabukuro-Vornhagen, A, Cornely, OA. Intensive care management of influenza-associated pulmonary aspergillosis. Clin Microbiol Infect 2019;25:1501\u20139.","DOI":"10.1016\/j.cmi.2019.04.031"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_068","doi-asserted-by":"crossref","unstructured":"Schauwvlieghe, AF, Rijnders, BJ, Philips, N, Verwijs, R, Vanderbeke, L, Van Tienen, C, et al.. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018;6:782\u201392.","DOI":"10.1016\/S2213-2600(18)30274-1"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_069","doi-asserted-by":"crossref","unstructured":"Buil, JB, Meijer, EF, Denning, DW, Verweij, PE, Meis, JF. Burden of serious fungal infections in The Netherlands. Mycoses 2020;63:625\u201331.","DOI":"10.1111\/myc.13089"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_070","doi-asserted-by":"crossref","unstructured":"Zhai, P, Ding, Y, Wu, X, Long, J, Zhong, Y, Li, Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020;55:105955.","DOI":"10.1016\/j.ijantimicag.2020.105955"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_071","doi-asserted-by":"crossref","unstructured":"Yao, X, Ye, F, Zhang, M, Cui, C, Huang, B, Niu, P, et al.. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732\u20139.","DOI":"10.1093\/cid\/ciaa237"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_072","doi-asserted-by":"crossref","unstructured":"Vincent, MJ, Bergeron, E, Benjannet, S, Erickson, BR, Rollin, PE, Ksiazek, TG, et al.. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005;2:1\u20130.","DOI":"10.1186\/1743-422X-2-69"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_073","doi-asserted-by":"crossref","unstructured":"Cortegiani, A, Ingoglia, G, Ippolito, M, Giarratano, A, Einav, S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020;57:279\u201383.","DOI":"10.1016\/j.jcrc.2020.03.005"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_074","doi-asserted-by":"crossref","unstructured":"Biot, C, Daher, W, Chavain, N, Fandeur, T, Khalife, J, Dive, D, et al.. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem 2006;49:2845\u20139.","DOI":"10.1021\/jm0601856"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_075","doi-asserted-by":"crossref","unstructured":"Colson, P, Rolain, JM, Raoult, D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents 2020;55:105923.","DOI":"10.1016\/j.ijantimicag.2020.105923"},{"key":"2025121207243553220_j_hmbci-2020-0096_ref_076","doi-asserted-by":"crossref","unstructured":"YAVUZ, S, \u00dcnal, S. Antiviral treatment of COVID-19. Turk J Med Sci 2020;50:611\u20139.","DOI":"10.3906\/sag-2004-145"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0096\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0096\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:27:55Z","timestamp":1765528075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0096\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2021,12,8]]}},"alternative-id":["10.1515\/hmbci-2020-0096"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2020-0096","relation":{},"ISSN":["1868-1891"],"issn-type":[{"type":"electronic","value":"1868-1891"}],"subject":[],"published":{"date-parts":[[2021,8,2]]}}}